<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>102(5)</volume><submitter>Stadler N</submitter><journal>Haematologica</journal><pagination>e191-e194</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5477622</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation.</pubmed_title><pmcid>PMC5477622</pmcid><pubmed_authors>Teschner D</pubmed_authors><pubmed_authors>Desuki A</pubmed_authors><pubmed_authors>Schulz C</pubmed_authors><pubmed_authors>Stadler N</pubmed_authors><pubmed_authors>Radsak MP</pubmed_authors><pubmed_authors>Kriege O</pubmed_authors><pubmed_authors>Michel C</pubmed_authors><pubmed_authors>Hasibeder A</pubmed_authors><pubmed_authors>Lopez PA</pubmed_authors><pubmed_authors>Weber ANR</pubmed_authors><pubmed_authors>Heβ G</pubmed_authors></additional><is_claimable>false</is_claimable><name>The Bruton tyrosine kinase inhibitor ibrutinib abrogates triggering receptor on myeloid cells 1-mediated neutrophil activation.</name><description/><dates><release>2017-01-01T00:00:00Z</release><publication>2017 May</publication><modification>2025-04-25T19:25:36.164Z</modification><creation>2025-04-06T07:57:34.328Z</creation></dates><accession>S-EPMC5477622</accession><cross_references><pubmed>28126969</pubmed><doi>10.3324/haematol.2016.152017</doi></cross_references></HashMap>